Response: Re: Dose Escalation Methods in Phase I Cancer Clinical Trials

被引：1
|
作者：
Le Tourneau, Christophe
Lee, J. Jack
Siu, Lillian L.
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2009年 / 101卷 / 24期
关键词：
D O I：
10.1093/jnci/djp401
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1733 / 1734
页数：2
相关论文
共 50 条
  • [31] Phase I dose-escalation oncology trials with sequential multiple schedules
    Burak Kürsad Günhan
    Sebastian Weber
    Abdelkader Seroutou
    Tim Friede
    BMC Medical Research Methodology, 21
  • [32] Phase I dose-escalation oncology trials with sequential multiple schedules
    Guenhan, Burak Kuersad
    Weber, Sebastian
    Seroutou, Abdelkader
    Friede, Tim
    BMC MEDICAL RESEARCH METHODOLOGY, 2021, 21 (01)
  • [33] Optimal biological dose: a systematic review in cancer phase I clinical trials
    Fraisse, J.
    Dinart, D.
    Tosi, D.
    Bellera, C.
    Mollevi, C.
    BMC CANCER, 2021, 21 (01)
  • [34] Optimal biological dose: a systematic review in cancer phase I clinical trials
    J. Fraisse
    D. Dinart
    D. Tosi
    C. Bellera
    C. Mollevi
    BMC Cancer, 21
  • [35] The Role of Age on Dose-Limiting Toxicities in Phase I Dose-Escalation Trials
    Schwandt, A.
    Harris, P. J.
    Hunsberger, S.
    Deleporte, A.
    Smith, G. L.
    Vulih, D.
    Anderson, B. D.
    Ivy, S. P.
    CLINICAL CANCER RESEARCH, 2014, 20 (18) : 4768 - 4775
  • [36] Finding Maximum Tolerated Dose in Phase I Oncology Clinical Trials with Bayesian Methods
    Sapi, Johanna
    ACTA POLYTECHNICA HUNGARICA, 2024, 21 (06) : 129 - 145
  • [37] Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trials
    Tu, Jieqi
    Chen, Zhengjia
    BIOMETRICAL JOURNAL, 2024, 66 (01)
  • [38] Incorporating a Patient Dichotomous Characteristic in Cancer Phase I Clinical Trials Using Escalation with Overdose Control
    Tighiouart, Mourad
    Cook-Wiens, Galen
    Rogatko, Andre
    JOURNAL OF PROBABILITY AND STATISTICS, 2012, 2012
  • [39] Adaptive dose modification for phase I clinical trials
    Chu, Yiyi
    Pan, Haitao
    Yuan, Ying
    STATISTICS IN MEDICINE, 2016, 35 (20) : 3497 - 3508
  • [40] A Phase I Dose-escalation Clinical Trial of Bronchoscopic Cryoimmunotherapy
    Velez, A.
    Laniado, I.
    Schluger, R.
    Demaio, A.
    Murthy, V.
    Bessich, J. L.
    Lukovnikova, A.
    Blaisdell, M.
    Krolikowski, K.
    Tsay, J. J.
    Segal, L. N.
    Sterman, D. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345